| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.0006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |